Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formula-based vs Weight-based Initial Insulin Dosing in T2DM
NCT05084079Phase 4Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2021
- Primary completion
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05084079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05084079.